AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Brockunier, LL Parmee, ER Ok, HO Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Tota, L Wyvratt, MJ Fisher, MH Weber, AE
Citation: Ll. Brockunier et al., Human beta 3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides, BIOORG MED, 10(18), 2000, pp. 2111-2114

Authors: Mathvink, RJ Tolman, JS Chitty, D Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Tota, L Wyvratt, MJ Fisher, MH Weber, AE
Citation: Rj. Mathvink et al., Potent, selective 3-pyridylethanolamine beta(3) adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore, BIOORG MED, 10(17), 2000, pp. 1971-1973

Authors: Ok, HO Reigle, LB Candelore, MR Cascieri, MA Colwell, LF Deng, L Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Strader, CD Tota, L Wang, P Wyvratt, MJ Fisher, MH Weber, AE
Citation: Ho. Ok et al., Substituted oxazole benzenesulfonamides as potent human beta(3) adrenergicreceptor agonists, BIOORG MED, 10(14), 2000, pp. 1531-1534

Authors: Feng, DQD Biftu, T Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Miller, RR Stearns, RA Strader, CD Tota, L Wyvratt, MJ Fisher, MH Weber, AE
Citation: Dqd. Feng et al., Discovery of an orally bioavailable alkyl oxadiazole beta(3) adrenergic receptor agonist, BIOORG MED, 10(13), 2000, pp. 1427-1429

Authors: Biftu, T Feng, DD Liang, GB Kuo, H Qian, XX Naylor, EM Colandrea, VJ Candelore, MR Cascieri, MA Colwell, LF Forrest, MJ Hom, GJ MacIntyre, DE Stearns, RA Strader, CD Wyvratt, MJ Fisher, MH Weber, AE
Citation: T. Biftu et al., Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta(3) adrenergic receptor agonist antiobesity agents, BIOORG MED, 10(13), 2000, pp. 1431-1434

Authors: Tamvakopoulos, CS Colwell, LF Barakat, K Fenyk-Melody, J Griffin, PR Nargund, R Palucki, B Sebhat, I Shen, X Stearns, RA
Citation: Cs. Tamvakopoulos et al., Determination of brain and plasma drug concentrations by liquid chromatography/tandem mass spectrometry, RAP C MASS, 14(19), 2000, pp. 1729-1735

Authors: Mathvink, RJ Tolman, JS Chitty, D Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Miller, RR Stearns, RA Tota, L Wyvratt, MJ Fisher, MH Weber, AE
Citation: Rj. Mathvink et al., Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide, J MED CHEM, 43(21), 2000, pp. 3832-3836

Authors: Shih, TL Candelore, MR Cascieri, MA Chiu, SHL Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Miller, RR Stearns, RA Strader, CD Tota, L Wyvratt, MJ Fisher, MH Weber, AE
Citation: Tl. Shih et al., L-770,644: A potent and selective human beta(3) adrenergic receptor agonist with improved oral bioavailability, BIOORG MED, 9(9), 1999, pp. 1251-1254

Authors: Naylor, EM Parmee, ER Colandrea, VJ Perkins, L Brockunier, L Candelore, MR Cascieri, MA Colwell, LF Deng, LP Feeney, WP Forrest, MJ Hom, GJ MacIntyre, DE Strader, CD Tota, L Wang, PR Wyvratt, MJ Fisher, MH Weber, AE
Citation: Em. Naylor et al., Human beta(3) adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides, BIOORG MED, 9(5), 1999, pp. 755-758
Risultati: 1-9 |